Bellerophon Therapeutics Inc (BLPH)
0.0565
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Bellerophon Therapeutics Enterprise Value: -3.691M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | -3.691M |
| May 23, 2024 | -3.693M |
| May 22, 2024 | -3.693M |
| May 21, 2024 | -3.587M |
| May 20, 2024 | -3.618M |
| May 17, 2024 | -3.685M |
| May 16, 2024 | -3.688M |
| May 15, 2024 | -3.693M |
| May 14, 2024 | -3.693M |
| May 13, 2024 | -3.694M |
| May 10, 2024 | -3.694M |
| May 09, 2024 | -3.694M |
| May 08, 2024 | -3.697M |
| May 07, 2024 | -3.697M |
| May 06, 2024 | -3.697M |
| May 03, 2024 | -3.618M |
| May 02, 2024 | -3.618M |
| May 01, 2024 | -3.754M |
| April 30, 2024 | -3.708M |
| April 29, 2024 | -3.708M |
| April 26, 2024 | -3.704M |
| April 25, 2024 | -3.709M |
| April 24, 2024 | -3.720M |
| April 23, 2024 | -3.665M |
| April 22, 2024 | -3.757M |
| Date | Value |
|---|---|
| April 19, 2024 | -3.716M |
| April 18, 2024 | -3.684M |
| April 17, 2024 | -3.715M |
| April 16, 2024 | -3.715M |
| April 15, 2024 | -3.684M |
| April 12, 2024 | -3.709M |
| April 11, 2024 | -3.732M |
| April 10, 2024 | -3.648M |
| April 09, 2024 | -3.648M |
| April 08, 2024 | -3.737M |
| April 05, 2024 | -3.709M |
| April 04, 2024 | -3.719M |
| April 03, 2024 | -3.719M |
| April 02, 2024 | -3.732M |
| April 01, 2024 | -3.702M |
| March 28, 2024 | -3.687M |
| March 27, 2024 | -3.687M |
| March 26, 2024 | -3.676M |
| March 25, 2024 | -3.649M |
| March 22, 2024 | -3.709M |
| March 21, 2024 | -3.702M |
| March 20, 2024 | -3.757M |
| March 19, 2024 | -3.741M |
| March 18, 2024 | -3.686M |
| March 15, 2024 | -3.770M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.92M
Minimum
May 11 2022
132.64M
Maximum
May 22 2020
16.27M
Average
5.389M
Median
Jun 14 2021
Enterprise Value Benchmarks
| Janux Therapeutics Inc | 1.701B |
| NovaBay Pharmaceuticals Inc | 5.655M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 27.27M |
| Theriva Biologics Inc | -10.02M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.921M |
| Total Expenses (Quarterly) | 2.17M |
| EPS Diluted (Quarterly) | -0.16 |
| Earnings Yield | -1.49K% |